Skip to contentC
Chemed Corp
C
CHEChemed Corp Q2 2022 · 10-Q
Revenue$297.78M$297.78M−4.5% vs Q2 2021 Net Income$66.46M$66.46M+17.6% vs Q2 2021 EPS Diluted$4.40$4.40+25.4% vs Q2 2021 Operating Income$91,938,000+28.2% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Chemed Corp · CIK 19584 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$43,619,000+363.4% Margins · derivedOperating margin30.9%+7.9 pt vs Q2 2021
Net margin22.3%+4.2 pt vs Q2 2021
ended Jun 30, 2022 · filed Jul 29, 2022 · 29 d after period end